OBJECTIVE: Trophoectoderm (TE) biopsy followed by targeted next generation sequencing for comprehensive chromosome screening (tNGS CCS) is increasingly used in ART. As more than 35% of transferred euploid embryos fail to achieve sustained implantation, simultaneous assessment of additional embryonic parameters in TE samples could be pursued to help increase implantation rates. However, due to the small sample size of TE biopsies (5-10 cells), tNGS CCS requires a pre-amplification step using polymerase chain reaction (PCR), and generates >500X10 9 amplicon copies for each sample, compared to only 5-10 copies of the original DNA, making it impossible to assess further genetic/epigenetic parameters from the same sample. In this study, we hypothesized that labeled-primers could allow the removal of PCR amplicons from the TE sample without impairing the diagnostic accuracy of tNGS CCS. DESIGN: Experimental study.
